A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
Study sponsor: Lexicon Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-01-14Actual
Enrollment · participants496Actual
Source updated2025-10-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.